Nicorette Freshfruit (Nicotine)

• Nicorette Freshfruit is used within the nicotine replacement therapy pathway to aid smoking cessation.
• Smoking cessation: reduces cravings and withdrawal symptoms, facilitating transition away from combustible tobacco.

• Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By binding to these receptors, it partially stimulates the same pathways activated by tobacco‑derived nicotine, thereby reducing the intensity of withdrawal symptoms and cravings while allowing the user to taper nicotine exposure gradually. The controlled delivery through oromucosal absorption provides steadier plasma nicotine levels compared with smoking, helping to normalize neurochemical activity during cessation.

Nicotine replacement therapy can be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Mouth irritation or soreness
• Hiccups or throat discomfort
• Nausea or mild stomach upset
• Headache
• Dizziness
• Unpleasant taste

Serious or Rare Side Effects

• Cardiovascular events such as hypertension, arrhythmia, or chest pain
• Severe allergic reactions including rash, swelling, or anaphylaxis
• Persistent vomiting or severe nausea
• Seizures
• Respiratory depression
• Prolonged dependence on nicotine

• When using Nicorette Freshfruit, several precautions should be observed to ensure safety.
• Assess cardiovascular status: patients with recent myocardial infarction or uncontrolled hypertension should use with caution.
• Avoid use in non‑smokers: nicotine is addictive and should not be initiated in nicotine‑naïve individuals.
• Monitor for dependence: prolonged use may lead to continued nicotine dependence.
• Consider pregnancy and lactation: risk is not well established; discuss with a healthcare professional before use.
• Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Nicotine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.
• Beta‑blockers: nicotine‑induced tachycardia may be masked, complicating monitoring.
• CYP2A6 inhibitors: can raise nicotine plasma concentrations, increasing side‑effect risk.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): may enhance dizziness.
• Antihypertensive agents: nicotine can reduce their efficacy, requiring blood pressure monitoring.
• Alcohol: concurrent use may increase nausea and gastrointestinal discomfort.